Word

LEYTEVU

Status

Pending

Status Code

686

Status Date

Tuesday, March 12, 2024

Serial Number

97790206

Mark Type

4000

Filing Date

Friday, February 10, 2023

Published for Opposition

Tuesday, March 12, 2024

Trademark Owner History

Amgen Inc. - Owner At Publication

Classifications

5 Pharmaceutical preparations and substances for use in the treatment of hematological, immune, autoimmune, inflammatory and respiratory diseases and disorders; pharmaceutical preparations and substances for the treatment of cancer and cardiovascular diseases and disorders; pharmaceutical preparations and substances used for the treatment of blood cells and blood vessel diseases and disorders; pharmaceutical preparations and substances for the treatment of oncological, and ophthalmic diseases and disorders; pharmaceutical preparations and substances for the treatment of inflammatory disorders of the central nervous system; pharmaceutical preparations and substances used for the treatment of hemolytic anemia, thrombocytopenia and kidney failure

Trademark Events

Mar 12, 2024

Official Gazette Publication Confirmation E-Mailed

Mar 12, 2024

Published For Opposition

Feb 21, 2024

Notification Of Notice Of Publication E-Mailed

Feb 21, 2024

Official Gazette Publication Confirmation E-Mailed

Feb 2, 2024

Approved For Pub - Principal Register

Jan 10, 2024

Teas/Email Correspondence Entered

Jan 9, 2024

Correspondence Received In Law Office

Jan 9, 2024

Teas Response To Office Action Received

Sep 29, 2023

Application Extension Granted/Receipt Provided

Sep 29, 2023

Application Extension To Response Period - Received

Aug 16, 2023

Notification Of Non-Final Action E-Mailed

Aug 16, 2023

Non-Final Action E-Mailed

Aug 16, 2023

Non-Final Action Written

Aug 15, 2023

Assigned To Examiner

Mar 1, 2023

New Application Office Supplied Data Entered

Feb 14, 2023

New Application Entered